Key Highlights
- ARK Invest allocated approximately $240 million to OpenAI Group equity across three exchange-traded funds on March 31, 2026
- OpenAI secured $122 billion in its most substantial financing round to date, establishing an $852 billion company valuation
- ARK expanded holdings in CoreWeave and DoorDash through additional share purchases
- The firm liquidated more than 600,000 Strata Critical Medical shares while reducing Veracyte and Teradyne holdings
- This transaction marks the first time retail ETF investors gain indirect exposure to a private enterprise through ARK’s publicly traded funds
Cathie Wood’s ARK Invest executed one of its most significant single-session transactions on March 31, 2026, acquiring approximately $240 million in OpenAI Group equity distributed across three exchange-traded funds.
The acquisition was distributed among the ARK Innovation ETF, the ARK Next Generation Internet ETF, and the ARK Blockchain and Fintech Innovation ETF. Each vehicle currently maintains approximately a 3% ownership position in OpenAI Group PBC, Series C shares.
Prior to this transaction, OpenAI equity was exclusively held within ARK’s closed-end Venture Fund. That fund initially invested during 2024 and subsequently increased its position with a $250 million commitment in October of the same year.
ARK’s investment coincides precisely with a substantial capital raise by OpenAI. The artificial intelligence company completed its largest financing round ever at $122 billion on the identical date, elevating its enterprise valuation to $852 billion.
OpenAI indicated the capital will fund semiconductor procurement, infrastructure expansion, and talent acquisition. The organization additionally facilitated approximately $3 billion in direct share sales to individual investors through a private placement coordinated with three prominent financial institutions.
OpenAI CFO Sarah Friar expressed the company’s commitment to providing retail investors access not merely to its technological innovations, but also to the potential financial returns associated with ownership.
Implications of OpenAI’s ETF Integration for Everyday Investors
By incorporating OpenAI equity into publicly listed ETFs, ARK is providing mainstream investors an avenue to gain exposure to a privately held enterprise. This approach represents an uncommon practice. Traditional retail investors typically lack access to pre-IPO private company securities.
However, there are considerations regarding valuation. While ETFs execute trades continuously throughout market hours, private company securities lack real-time pricing mechanisms. Portfolio managers depend on valuation models to establish fair value for these positions, and may need to liquidate more liquid holdings to accommodate shareholder redemption requests.
Cathie Wood addressed the investment decision, noting that within the fintech ecosystem, agentic artificial intelligence is positioned to generate extraordinary opportunities.
Additional Portfolio Adjustments by ARK on March 31
Beyond the OpenAI transaction, ARK purchased 26,515 shares of CoreWeave, a cloud computing infrastructure provider, valued at approximately $2.05 million. CoreWeave equity appreciated 12% during that trading session.
ARK additionally acquired 14,729 DoorDash shares for $2.21 million. This purchase followed a previous DoorDash acquisition one day earlier, expanding ARK’s exposure to the meal delivery industry.
Regarding divestments, ARK liquidated 612,483 Strata Critical Medical shares for $2.56 million. The enterprise delivers emergency logistics and clinical services to medical providers throughout the United States.
ARK also divested 6,204 Teradyne shares for $1.84 million and 115,718 Veracyte shares across its ARKK and ARKG portfolios, totaling $3.52 million. ARK had been systematically reducing its Veracyte allocation throughout the preceding week.
The OpenAI financing round concluded at an $852 billion valuation on March 31, 2026, coinciding with ARK’s $240 million allocation across its three primary exchange-traded funds.